Antibody Industrial Symposium 2023
Tours, France
Quality Assistance will attend
the 11th Antibody Industrial Symposium
Cécile Montagne, Charlotte Lentz, Key Account Managers, and Gery Van Vyncht, Scientific Director,
will be delighted to meet you at booth #24 to discuss your analytical needs and challenges related to antibodies, cell-based medicinal products and viral vectors
DON'T MISS OUR SCIENTIFIC TALK AND MEET US AT THE POSTER SESSION
On Friday June 23rd, at 11.30 AM, Géry Van Vyncht will present on MAM studies on benchtop MS instruments to boost QbD process development and high-throughput testing of major CQAs in a regulated environment. Make sure to follow his presentation to learn more about this study. This topic will also be presented during the poster session, on Thursday June 22nd, at 5.30 PM.
WHY PARTNER WITH QUALITY ASSISTANCE?
20 years’ experience with biotherapeutics:
To speed up the development and marketing of your biotherapeutics, Quality Assistance offers a complete analytical package to meet the EMA and FDA requirements, all on one site. Whether it is to extend your analytical capacities or to outsource parts or all of your analytical needs, our experts teams are here to support your developments of mAbs, ADCs and proteins.
10 years’ experience with CBMPs:
Cell-Based Medicinal Products are complex and require state-of-the-art analytical methodologies to evaluate their quality, safety and efficacy. Quality Assistance provides you with the scientific and technical support to develop and/or optimise these methods for use in a GxP-regulated environment.
Throughout non-clinical and clinical development, our experts provide you with the customised solutions in terms of analytical protocols and innovative technologies to help you move your product from discovery to the market place.
12 years’ experience with Viral Vectors:
Due to their complex structure and size, as well as a constantly evolving regulatory landscape, the physicochemical and biological characterisation of viral vector-based products is challenging.
Building on our considerable experience in the analysis of complex innovative drugs, Quality Assistance is continuously advancing ways to support the development of your products. We continuously invest in new technologies and machinery and are able to assist you in the development of your recombinant AAV products from early phases to marketing authorisation
ABOUT THE EVENT
Visit https://aiscongress.com/ for more information